No, the Miscarriage Risk from Amniocentesis Is Not 1 in 200 — That Number Is Decades Out of Date
“The miscarriage risk from invasive prenatal procedures like amniocentesis and CVS is approximately 1 in 200 pregnancies”
The argument in brief
The claim that amniocentesis carries a 1-in-200 miscarriage risk is an outdated figure from a 1978 study that has been repeated so often it became medical folklore. Modern evidence, including a 2019 meta-analysis and updated guidance from the American College of Obstetricians and Gynecologists, puts the current risk closer to 1 in 300 to 1 in 900 — roughly three to six times lower. The old number is more applicable to CVS, a different procedure, and even there the evidence is mixed.
Data: Tabor et al. 2019 meta-analysis; Wulff et al. 2016; ACOG 2020; Mujezinovic & Alfirevic 2007
Why it spread
The 1-in-200 figure was taught in medical schools and cited in textbooks for so long that it became a reflex — a simple, memorable number that patients and clinicians repeated without realizing the research behind it was nearly 50 years old. Updating a statistic that is already embedded in clinical culture and patient handouts takes time, and many sources simply have not caught up.
The claim that invasive prenatal testing carries a miscarriage risk of about 1 in 200 is partially false. That figure was a reasonable estimate for its time, but it is now significantly out of date for amniocentesis — the most common of these procedures — and continuing to cite it can cause real harm by discouraging people from testing they may genuinely benefit from.
The 1-in-200 figure traces back to a landmark 1978 study by the U.S. National Institute of Child Health and Human Development. For decades it was taught in medical schools and printed in textbooks, and it stuck. But medicine has changed. Ultrasound guidance is now standard, operators are more experienced, and needles are finer. The result is a dramatically safer procedure.
The American College of Obstetricians and Gynecologists updated its official guidance in 2020 to reflect a procedure-related miscarriage risk for amniocentesis of roughly 0.1 to 0.3 percent — about 1 in 300 to 1 in 900. A large 2019 meta-analysis by Tabor and colleagues, covering tens of thousands of procedures, landed in the same range. A major Danish cohort study published in 2016 by Wulff and colleagues found a risk of just 0.18 percent, or about 1 in 556.
To be fair to the claim, CVS — chorionic villus sampling, a different procedure done earlier in pregnancy — does carry a somewhat higher risk, estimated by ACOG at around 0.5 to 1.0 percent, which is closer to the old 1-in-200 figure. And a 2007 systematic review by Mujezinovic and Alfirevic found combined historical rates for both procedures that were higher than modern estimates. So the 1-in-200 number is not invented — it just no longer reflects what happens in a well-equipped clinic today, and it was never a precise fit for amniocentesis specifically.
This matters because risk figures directly shape decisions. A person told their chance of miscarriage is 1 in 200 may decline testing that could give them critical information about their pregnancy. When the actual risk is closer to 1 in 500 or 1 in 900, that decision changes. Outdated statistics, even well-intentioned ones, can do quiet damage.
This kind of misinformation spreads not through bad faith but through institutional inertia. A number gets embedded in training materials and patient leaflets, and it circulates long after the science has moved on. If you are discussing these procedures with a provider, it is worth asking what their center's specific complication rate is — experienced, high-volume operators tend to have the lowest risks of all.
Sources
- ACOG Practice Bulletin (American College of Obstetricians and Gynecologists)
ACOG updated its guidance to reflect that procedure-related miscarriage risk for amniocentesis is approximately 1 in 900 (0.1-0.3%), significantly lower than the older 1 in 200 figure, due to improvements in ultrasound guidance and operator experience.
- Cochrane Review / Tabor et al. (2019) - Amniocentesis and CVS meta-analysis
A large meta-analysis found the procedure-related fetal loss rate for amniocentesis to be approximately 0.11-0.30%, roughly 1 in 300-900, far lower than the historically cited 1 in 200 figure.
- NHS (UK National Health Service) - Amniocentesis information
The NHS states the miscarriage risk from amniocentesis is approximately 0.5-1%, but notes that more recent evidence suggests the risk may be as low as 0.1-0.3% when performed by experienced practitioners.
- ACOG / Society for Maternal-Fetal Medicine - CVS risk data
CVS carries a slightly higher procedure-related loss rate than amniocentesis, estimated at approximately 0.5-1.0% (1 in 100-200), making the 1 in 200 figure more applicable to CVS than to amniocentesis.
- Mujezinovic & Alfirevic (2007) - Obstetrics & Gynecology systematic review
This widely cited systematic review found procedure-related fetal loss after amniocentesis to be 0.6% (approximately 1 in 167) and after CVS to be 0.7% (approximately 1 in 143), suggesting the 1 in 200 figure is a reasonable historical estimate but modern rates are lower.
- Wulff et al. (2016) - Ultrasound in Obstetrics & Gynecology
A large Danish cohort study found the procedure-related miscarriage risk for amniocentesis to be 0.18% (approximately 1 in 556), confirming that modern risks are substantially lower than the traditional 1 in 200 estimate.
Related debunks
- UnverifiableCan't Confirm or Deny: Bill Ritter's Claim About His Cancer Treatment Is Unverifiable — Not False
- UnverifiableNo Evidence Bill Ritter Has Been Diagnosed With Alzheimer's — The Claim Is Unverified
- UnverifiableYes, Whey, Soy, and Pea Proteins Really Can Leave a Bad Aftertaste — And Science Explains Why